|
|
18-20, rue Pasteur Le Kremlin-Bictre Cedex, 94278 France phone:(33) (1) 45 15 40 40 fax:(33) (1) 45 15 40 41
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.caconcology.com
|
|
| Research Sector |
Healthcare Services |
|
 |
| Summary Description |
| Research on oncology and development of agent and regimens for patients. |
 |
| Management |
| Ludo Reynders, Ph.D., President & Chief Executive Officer; Rachel Selisker, Executive Vice President and Chief Financial Officer; Vito Mangiardi , President, North American Operations; John Hall, Ph.D., President, European Operations; John Harrington, Executive Vice President, Human Resources; Sara Strassle, Senior Vice President, Corporate Communication; Al Cavagnaro, Vice President, Corporate Legal Affairs |
| |
|
|
| |
|
| Keywords |
| oncology, agent, regimen, cytotoxics, antibody, antiemetics |
|
|
|
| Description |
|
CAC is a contract research organization focused solely on oncology and specialised in early stage development of both single agent and combination regimens for the treatment and care of patients. |
 |
| Products / Services |
CAC's experience include cytotoxics, monoclonal antibodies, cell-based therapies, antiangiogenic agents, apoptosis inducers, and hormonal therapies. Supportive treatments may encompass antiemetics, hematopoietic growth factors, chemoprotectants, and neuroprotectants.
|
 |
 |
|
|
|
|
|
|